GLP-1 Titles That Get Clicked
Number first
#1: Don’t Fall for $99 GLP-1 Ads #glp1 #weightloss #shortsfeed #shorts #fypage #fypyoutube #truestory (LifeRx md). Places 2 to 5 are decoded in the report.
Start using it today. Your niche is done within 7 days of purchase.
Your AI knows YouTube. It does not know your niche.You are buying the niche data, rules and tools it needs: we decoded 212 glp-1 videos into the formulas that win.
GLP-1 is a topic inside Bariatric Surgery. One purchase includes both.
212 glp-1 videos decoded, 88.9M views behind them. Titles, thumbnails, hooks, scripts, descriptions, story and editing. Read it online or download the PDF.
Number first
#1: Don’t Fall for $99 GLP-1 Ads #glp1 #weightloss #shortsfeed #shorts #fypage #fypyoutube #truestory (LifeRx md). Places 2 to 5 are decoded in the report.
White coat or clean background
#1: Where to inject for MAXIMUM GLP-1 Weight Loss | Breaking down the data (Dr. Kevin Joseph, DO). Places 2 to 5 are decoded in the report.
Name the patient first
#1: Don’t Fall for $99 GLP-1 Ads #glp1 #weightloss #shortsfeed #shorts #fypage #fypyoutube #truestory (LifeRx md). Places 2 to 5 are decoded in the report.
Clinical finding opens
#1: Don’t Fall for $99 GLP-1 Ads #glp1 #weightloss #shortsfeed #shorts #fypage #fypyoutube #truestory (LifeRx md). Places 2 to 5 are decoded in the report.
Drug name in first sentence
#1: Don’t Fall for $99 GLP-1 Ads #glp1 #weightloss #shortsfeed #shorts #fypage #fypyoutube #truestory (LifeRx md). Places 2 to 5 are decoded in the report.
State the patient assumption
#1: Where to inject for MAXIMUM GLP-1 Weight Loss | Breaking down the data (Dr. Kevin Joseph, DO). Places 2 to 5 are decoded in the report.
The number one video in every category, decoded, plus one part of each winning pattern and the first video to make. Online and as a PDF. The full report has all five in every category.
The glp-1 evidence
Real winning long-form and Shorts videos behind the patterns in this Decode. Browse the source examples before you decide what to make.
Where to inject for MAXIMUM GLP-1 Weight Loss | Breaking down the dataDr. Kevin Joseph, DO · 1.4M views
10 Best Foods to Eat on GLP-1 meds Ozempic, Wegovy, Mounjaro & Zepbound : Doctor ExplainsBazgha Khalid, MD · 1.1M views
This 99 Cent Food Mimics Ozempic — Here's How (And How to Use It): Weight Loss Doctor ExplainsBazgha Khalid, MD · 1.0M views
Obesity Medicine Doctor Explains: The Surprising Benefits of Tirzepatide Beyond Weight LossBazgha Khalid, MD · 266K views
Diarrhea on GLP-1? Here's What's Actually HappeningGLP-1 Hub · 16K views
Don’t Fall for $99 GLP-1 Ads #glp1 #weightloss #shortsfeed #shorts #fypage #fypyoutube #truestoryLifeRx md · 30.6M views
The Only GLP-1 Provider That Never Raises Your Price #glp1 #weightloss #fypyoutube #shortsfeed #foodLifeRx md · 27.4M views
Signs Your GLP-1 Dose Is Too High OR Too Low #weightlosstips #relatable #shorts #fypLifeRx md · 1.8M views
Some Rather Disappointed GLP1 News 😢The Better Living PA · 46K views
Two months off a GLP1 and this happened (not what you think)Dr. Spencer Nadolsky · 984K views
How to take your Ozempic injection #shorts #ozempic #glp1 #semaglutide #weightloss #tutorialHella Bella · 968K views212 GLP-1 videos decoded. We find what repeats in the winners. Your AI uses it.
Where to inject for MAXIMUM GLP-1 Weight Loss | Breaking down the data
Where to action for superlative niche keyword outcome | credibility signal
This title works because it answers a specific, actionable question (where to inject) while promising a concrete outcome (maximum weight loss).

All right, if you've seen those ads saying you can get GLP-1 for $99 per month, do not be fooled. That is not the price of GLP-1. It's a membership fee that they're charging you, and even worse, they're going to bill you for multiple months up…
The hook immediately contradicts a claim the viewer has likely encountered ('$99/month GLP-1'), which stops the scroll because it promises to reveal a hidden truth.
hey what's up guys in today's video I'm going to be breaking down the importance of injection site when it comes to weight loss and appetite suppression and if rotating injection sites actually makes a difference I'm…
Tight 30-second cold open with immediate value promise, slows through the educational middle (mechanism of action, study breakdown, data analysis), accelerates through personal…
Showing you exactly how I take my weekly Ozempic injection.
When the narrator switched to thigh injection, he experienced zero appetite suppression for an entire week
Does injection site location matter for weight loss and appetite suppression, and should you rotate injection sites?
We decode your niche. Use it with the AI and the YouTube tools you already have.
Ranked by the views behind each topic
Built on a real video with 27.4M views
Based on: “The Only GLP-1 Provider That Never Raises Your Price #glp1 #weightloss #fypyoutube #shortsfeed #food”, LifeRx md
Written from the thumbnails that won in glp-1
Clean white background. Your clinic logo or name on a price tag held up to camera, centered. Overlay text in bold red reads 'PRICE NEVER CHANGES.' Eye lands on the price tag first, then the text above it.
Read from the real opening lines in glp-1
For long form, write your first sentence before you film anything else.
How it works
Pick your niche. We have already decoded the videos that won in it: titles, thumbnails, hooks, scripts and edits.
Connect it to the AI you already use. About 2 minutes, once. Nothing to learn.
Where to action for superlative niche keyword outcome | credibility signal
From 5 winners · 3.9M viewsAsk for your next title, thumbnail or script. Your AI answers from what already won, not from a guess.
Your titles, scripts and descriptions are written by the AI you connect, on your own account, from the decoded niche data and the formulas we hand it. That is the point of the product and the reason nothing here is metered: you are not buying tokens, you are buying the research that makes the AI you already have worth talking to about your business. Thumbnails work either way. ChatGPT or Gemini can make the image in the connected chat. Claude gives you the finished image prompt to use in the image app you choose. Niche King does not render a connected customer’s thumbnail on its own account.
The difference is whether your AI has seen what already won in your niche.
What we found in glp-1
This is the decoded GLP-1 niche for bariatric clinics. Across 212 videos and 88,906,592 views, three things win: a named drug, a named doctor credential, and a specific patient problem in the same title. The single biggest Short, LifeRx md's 'Don't Fall for $99 GLP-1 Ads,' pulled 30,614,859 views by warning patients against a competitor pricing tactic in under 40 seconds. The single biggest long-form video, Dr. Kevin Joseph's 'Where to inject for MAXIMUM GLP-1 Weight Loss,' reached 1,425,867 views by combining a clinical data breakdown with an injection-site question patients are already asking. Bazgha Khalid, MD built three videos over one million views each by opening every one with 'If you are on a GLP-1 medication like Ozempic' and naming Wegovy, Mounjaro, and Zepbound in the title. The niche does not reward general weight loss content. It rewards videos that answer the exact question a patient types the night before their appointment.
Counted from the titles of every glp-1 video we decoded, ranked by the views behind them. Not a guess at what your customers care about. A measurement of it.
Each one answers a topic glp-1 already wins on, in the format that actually wins it here. The titles follow the patterns we decoded from the winners, not a template.
3 decoded videos on glp-1 provider · 27.7M views behind it.
Read from: The Only GLP-1 Provider That Never Raises Your Price #glp1 #weightloss #fypyoutube #shortsfeed #food · LifeRx md41 decoded videos on weight loss · 8.3M views behind it.
Read from: Where to inject for MAXIMUM GLP-1 Weight Loss | Breaking down the data · Dr. Kevin Joseph, DO32 decoded videos on doctor explains · 6.5M views behind it.
Read from: 10 Best Foods to Eat on GLP-1 meds Ozempic, Wegovy, Mounjaro & Zepbound : Doctor Explains · Bazgha Khalid, MD7 more, each with its thumbnail, inside the decode.
We analyzed 212 GLP-1 videos with 88,906,592 views behind them and found the patterns that separate a video with 16,000 views from one with 30 million. This niche is built from named drugs, named credentials, and patient fears about dosing, side effects, and cost. Follow this strategy and you will know exactly what to film, what to put on the thumbnail, and what to say in the first three seconds.
Every long-form title winner names a specific drug or the term GLP-1, pairs it with a credential signal, and leads with a number or a specific problem. Dr. Kevin Joseph's 'Where to inject for MAXIMUM GLP-1 Weight Loss | Breaking down the data' at 1,425,867 views uses a superlative and a credibility signal separated by a pipe. Bazgha Khalid's 'This 99 Cent Food Mimics Ozempic' at 1,024,497 views leads with a price point and a bold comparison. The Shorts winners work differently. LifeRx md's two biggest titles, 30,614,859 views and 27,447,512 views, use a negation warning or an exclusivity claim and keep the drug name in the first six words. 'Signs Your GLP-1 Dose Is Too High OR Too Low' at 1,829,820 views uses a diagnostic frame. The one title that underperforms in this group, GLP-1 Hub's 'Diarrhea on GLP-1? Here's What's Actually Happening' at 16,026 views, names the problem but offers no credential and no number.
Long form that won:
Shorts that won:
What to do: For long-form videos, open with a number or a price point, name at least one brand drug by name, and close with your credential. Keep the whole title under 70 characters. For Shorts, open with a negation or an exclusivity claim, put GLP-1 in the first five words, and move every hashtag to the description. Write three title options before filming. The one that names Ozempic, Wegovy, Mounjaro, or Zepbound alongside a specific patient fear will outperform the generic version.
The long-form winners split into two clear looks. Bazgha Khalid, MD appears in white coat, pointing toward a food or product, with red text stating the bold claim and white explanatory text beside it. This layout appears across the 1,136,602-view food video and the 1,024,497-view beans video. Dr. Kevin Joseph's 1,425,867-view thumbnail has no face at all: a Mounjaro injection pen on a neutral background with question text in split colors. GLP-1 Hub's 16,026-view thumbnail uses a hand gesture with lightning bolts and a problem word in large outlined text on a bright gradient. The no-face thumbnail at 1.4 million views and the face-forward thumbnail at 1.1 million views both work, but every winner uses high contrast, a dominant text overlay of five words or fewer, and one clear object or person as the focal point. There are no busy collages among the winners.
5 decoded examples and the instruction for this chapter are in the full Niche YouTube Strategy.
Long-form hooks split into two patterns. Bazgha Khalid opens with direct address: 'If you are on a GLP-1 medication like Ozempic' in the first three seconds, then states a credential, then opens a loop. This pattern appears in the 1,136,602-view food video and the 1,024,497-view beans video. GLP-1 Hub's contrarian opener, 'The number one diarrhea trigger on GLP-1s is not the medication,' is the cleanest three-second hook in the corpus even at 16,026 views. For Shorts, LifeRx md's two biggest videos at 30,614,859 and 27,447,512 views both open with 'All right' followed immediately by a negation or a bold claim. Dr. Spencer Nadolsky's 984,002-view Short opens with a personal experiment: 'I decided to take an 8-week break from my GLP-1.' The pattern across all five Shorts winners is that the contradiction or the warning lands inside the first three seconds, not after a greeting.
10 decoded examples and the instruction for this chapter are in the full Niche YouTube Strategy.
Long-form scripts follow a four-act structure across all five winners. Dr. Kevin Joseph's 1,425,867-view video opens with the clinical finding, explains the mechanism, presents the Eli Lilly study data, then closes with practical guidance and a single CTA at 11:59. Bazgha Khalid's 1,136,602-view food video runs ten food categories each backed by a clinical reference, then closes with myths versus facts. The 1,024,497-view beans video plants a mid-video comment question at 6:15 before the final payoff. GLP-1 Hub's video at 16,026 views offers a lead magnet QR code at 1:40, immediately after the intro, which is the earliest CTA placement in the corpus. For Shorts, LifeRx md's two biggest videos follow hook, problem escalation, solution reveal, and a single link-in-bio CTA. Dr. Spencer Nadolsky's 984,002-view Short has no CTA at all and relies entirely on the story.
10 decoded examples and the instruction for this chapter are in the full Niche YouTube Strategy.
Every long-form winner uses the value-stack pattern: a benefit-driven first sentence that names a specific drug, followed by two or three short paragraphs covering mechanism, evidence, and a soft CTA. Dr. Kevin Joseph's 1,425,867-view description opens with a lead question containing the primary keyword and at least one drug name in the first 125 characters. Bazgha Khalid's descriptions name Ozempic, Wegovy, Mounjaro, and Zepbound in the first paragraph. GLP-1 Hub's 16,026-view description front-loads two CTA links before the value stack, which is the one move the analysis flags as a mistake. Shorts descriptions from LifeRx md at 30,614,859 and 27,447,512 views are short: a pain-point lead, two or three sentences explaining the problem, a link, and nothing else. All five long-form winners use three hashtags or fewer. The Shorts descriptions that over-stack hashtags are flagged as underperforming that specific format.
10 decoded examples and the instruction for this chapter are in the full Niche YouTube Strategy.
Long-form winners use a three-act structure: establish the misconception or the patient problem, explain the mechanism with evidence, then deliver the practical answer. Dr. Kevin Joseph's 1,425,867-view video names three FDA-approved injection sites in act one, presents the Eli Lilly study in act two, and closes with practical guidance. Bazgha Khalid's 1,024,497-view beans video opens with an impossible-sounding claim, explains the two biological pathways that make it true, then delivers the practical application. GLP-1 Hub's video flips the assumption in act one: diarrhea is not caused by the medication. Every story turn is a reframe. The Shorts winner from Dr. Spencer Nadolsky at 984,002 views is a personal experiment with a surprise outcome: the assumption that an 8-week break would hold the results is the setup, and the contradiction is the payoff.
5 decoded examples and the instruction for this chapter are in the full Niche YouTube Strategy.
Topic: doctor explains. Format: long form. Working title: 10 Best Foods to Eat on GLP-1 Meds Ozempic Wegovy Mounjaro and Zepbound: Obesity Doctor Explains.
The evidence says face-to-camera videos with a visible credential win across long-form GLP-1 content. Bazgha Khalid, MD built three videos over one million views each by appearing in a white coat and pointing at the relevant object. GLP-1 Hub's faceless video on diarrhea reached only 16,026 views by comparison. Being on camera with a clinical credential visible is the single most repeated pattern in the long-form winners.
The corpus shows Ozempic, Wegovy, Mounjaro, and Zepbound named together in the same title drive the highest click volume for long-form content. Bazgha Khalid's '10 Best Foods to Eat on GLP-1 meds Ozempic, Wegovy, Mounjaro and Zepbound' reached 1,136,602 views. Tirzepatide and semaglutide also appear in winning titles. Use the brand name and the generic name in the same video to capture both search terms.
Both formats win in this niche but for different reasons. LifeRx md's Short 'Don't Fall for $99 GLP-1 Ads' reached 30,614,859 views by warning patients about competitor pricing. Dr. Kevin Joseph's long-form 'Where to inject for MAXIMUM GLP-1 Weight Loss' reached 1,425,867 views with a clinical data breakdown. Shorts bring top-of-funnel attention fast. Long-form builds the trust that makes someone book an appointment. The clinic that does both captures both audiences.
The 'doctor explains' topic cluster has 32 videos and 6,514,374 views behind it, with Bazgha Khalid's food video as the best single example at 1,136,602 views. A video titled '10 Best Foods to Eat on GLP-1 Meds Ozempic Wegovy Mounjaro and Zepbound: Obesity Doctor Explains' is the proven entry point. It names the drugs, signals authority, and answers a question every GLP-1 patient is already asking.
Long-form winners in this corpus run to approximately ten to twelve minutes based on CTA timestamps. Dr. Kevin Joseph's subscribe CTA appears at 12:00. Bazgha Khalid's like CTA appears at 10:34. Shorts winners run under 40 seconds. There is no winning video in this corpus that runs two to four minutes. Either go deep for ten minutes or go fast under one minute. The middle length does not appear among the top performers.
Name the patient and their situation before anything else. Bazgha Khalid opens with 'If you are on a GLP-1 medication like Ozempic' in the first three seconds across multiple million-view videos. GLP-1 Hub's contrarian opener, 'The number one diarrhea trigger on GLP-1s is not the medication,' is the cleanest three-second hook in the corpus. Both patterns name the drug and the problem before second three. Do not open with a greeting, your name, or what you are going to cover.
The highest-viewed Short in the entire corpus, LifeRx md's 'Don't Fall for $99 GLP-1 Ads' at 30,614,859 views, is built entirely around a competitor pricing warning. The second-highest Short, 'The Only GLP-1 Provider That Never Raises Your Price' at 27,447,512 views, uses a price-stability claim as its central hook. Addressing the $99 telehealth ad directly and explaining what patients are actually getting is the most proven Short format in this niche.
GLP-1 Hub's video on diarrhea reached 16,026 views. LifeRx md's Short reached 30,614,859 views. The difference is not following size: it is the specificity of the problem named in the title and the speed of the hook. The niche rewards specific patient problems paired with named drugs, regardless of channel size. A new channel with the right title structure can outperform an established channel with a vague one.
The two most consistent long-form thumbnail patterns are: a doctor in a white coat pointing at a relevant object with a five-word red text overlay, or the relevant object centered on a clean background with a question in split colors. Bazgha Khalid uses the pointing doctor across multiple million-view videos. Dr. Kevin Joseph's 1,425,867-view thumbnail has no face at all and still wins. Both use high contrast and one focal point. Never use a collage.
Long-form winners use one CTA at the end, placed after the full value has been delivered. Dr. Kevin Joseph's like and subscribe CTAs appear at 11:59 and 12:00 respectively. Bazgha Khalid's like CTA at 10:34 is tied to a specific question to the audience about their GLP-1 experience. GLP-1 Hub is the only winner to place a lead magnet CTA early, at 1:40, and its view count of 16,026 is the lowest in the long-form group. Earn the CTA with the content first.
Put GLP-1 and at least one brand drug name in the first 125 characters of your description. Every long-form winner in this corpus does this. Follow with two short paragraphs covering what the video explains and your clinical credentials. Add your booking link with one sentence of context. End with three hashtags: glp1, weightloss, and the specific drug name from the video. The corpus analysis flags descriptions with more than five hashtags as underperforming the format.
Based on the topics with the most views behind them, the three biggest patient fears are being overcharged or misled by a provider, dosing incorrectly, and not knowing what to eat. LifeRx md's pricing Shorts account for over 58 million combined views. The dosing topic cluster across 'glp-1 dose,' 'dose is too,' 'too high,' and 'signs your glp-1' totals nearly 8 million views. The food topic cluster sits at nearly 2 million views for just two videos. Film in that order.
Dr. Spencer Nadolsky's 984,002-view Short 'Two months off a GLP1 and this happened' is a personal experiment story with no props. It works because the story structure creates the visual tension. For long-form, Bazgha Khalid and Dr. Kevin Joseph both use physical objects or clinical props as a focal point. If you film a talking head with no props and no story tension, the evidence in this corpus does not support it outperforming a video with a physical object or a personal experiment.
Bazgha Khalid's subscribe CTA across multiple videos includes the phrase 'new video every week.' Dr. Kevin Joseph uses a similar weekly cadence signal. The corpus does not contain evidence about posting frequency and view count because frequency data was not part of the decoded corpus. What the evidence does show is that every top channel in this niche signals a consistent schedule to viewers as part of its value proposition.
You get your niche data, the rules and the tools. No courses.
Start using it today. Your niche research and decodes are done within 7 days of purchase.
Rather pay once? Lifetime Access: $497 once.
Running several channels? Lifetime Access, 10 channels: $997 once.
Lifetime access lasts for as long as Niche King provides this product. Your connected AI runs on your own account; third-party AI credits are not included.
Included with every purchase. If it is not a fit, request a full refund through a support ticket within 14 days of purchase. Earlier purchases keep the guarantee offered at their checkout.
You can, and it gives you general YouTube advice. It does not arrive with our checked videos, source-linked formulas and ranked topics for your niche. That evidence has to be gathered and decoded before your AI can use it.
Your Niche Strategy and its source-backed video ideas, title structures, thumbnail briefs, hooks, script and editing rules, the tools and the connection that lets your own AI use that evidence, every new niche we open, and support through a form. Yearly is billed $297 once a year; or pay $497 once for Lifetime. One active niche at a time: pick a finished niche now, or request yours and we will have its research and decodes complete within 7 days of purchase.
Paste one link into ChatGPT, Claude or Gemini and press Allow. There is no file to edit and no key to copy. It takes about 2 minutes. After that you talk to your AI in plain English, the same way you already do.
Yes, and that is deliberate. Your AI does the thinking on your own account, which is why everything here is unlimited and nothing is metered. You are paying for the data, not for the compute. It is also why this can cost what it costs: if I ran the AI for you, the price would have to cover the compute.
Maybe already. Pick a finished niche now, or request yours and we will have its research and decodes complete within 7 days of purchase. Every new niche we finish is open to every customer.
Yes. A free account, with just your email, shows a sample of a finished niche: one part of each winning pattern and the first video to make. The full rules, the decoded source videos, the rest of the ranked list and the tools are part of the paid plan.
No. This is for creators and businesses who already know the niche they want to make videos in. Pick a finished niche, or request yours and we will have its research and decodes complete within 7 days of purchase. We supply the research, formulas and AI tools for that niche, not a niche-discovery course.
You choose one active niche from the finished library at a time. Lifetime can switch anytime; Yearly can switch once a week. One niche at a time gives your AI deep context instead of a shallow pile of unrelated data. Nothing is metered per question by Niche King.
You choose. Yearly is $24.75 a month, billed $297 once a year, and renews automatically until you cancel (cancel anytime in your account). Lifetime is $497 once and never renews. There is no payment plan for either.
Access for as long as Niche King provides this product, including the niches and updates we publish. There is nothing to cancel because it never renews.
Lifetime Access, 10 channels is $997 once, for agencies and businesses with up to 10 channels. It is a single payment; there is no payment plan for it.
No. The product is the working Strategy, evidence and tools. A finished niche is ready as soon as you connect. A niche you request is complete within 7 days of purchase. If you get stuck, the support form is there whenever you need it.
The headline is a promise, not a measured result yet. The 14-Day Fit Guarantee backs it: use it on your real work, and if your AI is not clearly better for your niche, ask for a refund.
Every purchase has a 14-day Fit Guarantee. Earlier buyers keep the window offered at their checkout. Use the live Strategy in your real work. If it is not right for your business, request a full refund through a support ticket within the applicable window. When a refund is issued, access to your Niche Strategy, the tools and the MCP data layer ends immediately.
Anyone still trying to decide what niche to enter, anyone wanting somebody to run their channel, or anyone expecting every niche to be active at the same time. This is a working Strategy for one chosen niche at a time, not a niche finder or a done-for-you service.
Connect your niche to your AI in about 2 minutes and make the next video with evidence.
Get Instant Access